| Entry |
|
|---|
| Name |
Thalidomide (JAN/USP/INN);
Thalomid (TN);
Thaled (TN)
|
|---|
| Product |
|
|---|
| Formula |
C13H10N2O4
|
|---|
| Exact mass |
258.0641
|
|---|
| Mol weight |
258.2295
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Interaction |
|
|---|
| Structure map |
| Hypnotics | | Immunosuppressive agents |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D00754 Thalidomide (JAN/USP/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AX Other immunosuppressants
L04AX02 Thalidomide
D00754 Thalidomide (JAN/USP/INN)
USP drug classification [BR:br08302]
Antineoplastics
Antiangiogenic Agents
Thalidomide
D00754 Thalidomide (JAN/USP/INN)
Antineoplastics [BR:br08308]
Biologic response modifiers
Nonspecific immunomodulation
Thalidomide [ATC:L04AX02]
D00754 Thalidomide (JAN/USP/INN)
 |
|---|
| Other DBs |
CAS: 50-35-1 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 19
1 N1y N 24.4297 -17.9205
2 C1y C 25.8285 -17.9088
3 C5x C 23.6163 -19.0616
4 C5x C 23.6046 -16.7910
5 C5x C 26.5422 -16.6857
6 C1x C 26.5482 -19.1142
7 C8y C 22.2821 -18.6228
8 O5x O 24.0552 -20.3841
9 C8y C 22.2763 -17.2300
10 O5x O 24.0260 -15.4627
11 N1x N 27.9293 -16.6506
12 O5x O 25.8168 -15.4684
13 C1x C 27.9761 -19.0791
14 C8x C 21.0825 -19.3248
15 C8x C 21.0590 -16.5452
16 C5x C 28.6490 -17.8560
17 C8x C 19.8653 -18.6402
18 C8x C 19.8594 -17.2475
19 O5x O 30.0477 -17.8326
BOND 21
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 4 10 2
10 5 11 1
11 5 12 2
12 6 13 1
13 7 14 1
14 9 15 1
15 11 16 1
16 14 17 2
17 15 18 2
18 16 19 2
19 7 9 2
20 13 16 1
21 17 18 1
|
|---|
